program｜The 94th Annual Meeting of the Japanese Pharmacological Society

Symposium26

Frontiers in the research on vascular endothelial cells and drug development

3-S26-19:0010:30 Relationship between AGE scavenging and angiogenesis in endothelial cell Takashi Nishinaka¹, Omer Faruk Hatipoglu¹, Hidenori Wake¹, Shuji Mori², Masahiro Nishibori³, Hideo Takahashi¹ ¹Dept. Pharmacol., Facul. Med., Kindai Univ., ²Dept. Pharmcol., Sch. Pharmacy, Shujitsu Univ., ³Dept. Pharmacol., Sch. Med. Dent. Pharm. Sci., Okayama Univ.

3-S26-29:0010:30 Exploratory studies on novel therapeutic targets for intraocular vascular lesions Hideaki Hara, Shinsuke Nakamura Mol. Pharmacol., Gifu Pharmaceut. Uni.

3-S26-39:0010:30 Dynamics of HMGB1 in vascular endothelial cells and tumor vessels-targeting therapy using conjugated anti-HMGB1 mAb for cancers Masahiro Nishibori¹, Shangze Gao¹, Naoko Tomonobu², Masakiyo Sakaguchi² ¹Dept of Pharmacol, Okayama Univ Grad Schl Med, ²Dept of Cell Biol, Okayama Univ Grad Schl Med

3-S26-49:0010:30 The role of tumor endothelial cells in cancer progression Kyoko Hida Vasc Biol.Mol.Pathol., Grad. Sch.Dent Med, Hokkaido Univ

Symposium29

Frontiers in muscle research: towards therapy and drug development

3-S29-110:3012:00 Regulation of functional coupling between sarcolemmal and sarcoplasmic reticulum Ca²⁺ channels in striated muscles by junctophilins Tsutomu Nakada¹, Hiroyuki Kawagishi², Takuro Tomita², Mitsuhiko Yamada² ¹Dept. Instr. Anal., Res. Ctr. Spt. Adv. Sci., Shinshu Univ., ²Dept. Mol. Pharmcol., Shinshu Univ. Sch. Med.

3-S29-210:3012:00 How to elucidate mechanisms underlying force changes in skeletal muscle in vivo: techniques combining in vivo contractions and mechanically skinned fibers Daiki Watanabe, Masanobu Wada Grad. Sch. Integr. Sci., Hiroshima Univ.

3-S29-310:3012:00 Therapeutic effects of novel type1 ryanodine receptor inhibitor on muscle diseases Toshiko Yamazawa Dept. Mol. Physiol., Jikei Univ. Sch. Med., Tokyo, Japan

3-S29-410:3012:00 Molecular mechanism underlying myonuclei accretion during resistance training So-Ichiro Fukada Graduate School of Pharmaceutical Sciences, Osaka University

Oral Sessions

Neurodegeneration (4), Otolaryngology, Ophthalmology (1)

3-O-C1-114:3014:42 Hearing impairment associated with dysmyelination of the peripheral cochlear nerve in muscular dystrophy caused by aberrant α-dystroglycan glycosylation Shigefumi Morioka^1,2,3, Hirofumi Sakaguchi³, Hiroaki Mohri², Mariko Ikeda⁴, Motoi Kanagawa⁵, Naoaki Saito², Takehiko Ueyama² ¹Dept. of Otolaryngology, Kyoto City Hosp., ²Lab. of Mol. Pharmacol., Biosignal Research Center, Kobe Univ., ³Dept. of Otolaryngology-Head and Neck Surgery, Kyoto Prefectural Univ. of Med., ⁴Dept. of Clinical Genetics, Fujita Health Univ. Hosp., ⁵Dept. of Mol. Cardiovascular Biol. and Pharmacol. Ehime Univ.

3-O-C1-214:4214:54 An attempt to establish an assay system for protective agents against glutamate-induced neurotoxicity using QNR/D cells, a cell line derived from quail embryotic neruroretinas Kenji Sakamoto, Kazuya Katsumata, Asami Mori, Takashi Uezono Lab. Med. Pharmacol., Fac. Pharma-Sci., Teikyo Univ.

3-O-C1-314:5415:06 Early reactive gliosis at optic nerve head in normal-tension glaucoma Youichi Shinozaki^1,2, Kazuhiko Namekata³, Kenji Kashiwagi⁴, Nobuhiko Ohno^5,6, Eiji Shigetomi^1,2, Takayuki Harada³, Schuichi Koizumi^1,2 ¹Dept. Neuropharm., Grad. Sch. Med., Univ. Yamanashi, ²YiBIC, Univ Yamanashi, ³Vis. Res. Project., Tokyo Metr. Inst. Med. Sci., ⁴Dept. Ophthalmol, Interdiscip. Grad. Sch. Med. Univ. Yamanashi, ⁵Dev. Ultrastruct. Res., Natl. Inst. Physiol. Sci., ⁶Div. Anatomy, Jichi Med. Univ.

3-O-C1-415:0615:18 P2Y₁ receptor is a novel target for anti-glaucoma treatment Hamada Kentaro¹, Yoichi Shinozaki^1,2, Namekata Kazuhiko³, Nobuhiko Ohno^4,5, Takahiko Segawa⁶, Takayuki Harada³, Kenji Kashiwagi⁷, Shuichi Koizumi^1,2 ¹Dept. Neuropharmacol., Interdiscip. Grad. Sch. Med. Univ. Yamanashi, ²Cent. Life Sci. Res., Univ. Yamanashi., ³Vis. Res. Project, Tokyo Metr. Inst. Med. Sci.,, ⁴Dev. Ultrastruct. Res., Natl. Inst. Physiol. Sci.,, ⁵Div.Anatomy,Jichi 6 Med.Univ.,, ⁶The Center for life Science Research, Univ.Yamanashi, ⁷Dept.Opthalmol.,Interdiscip.Grad.Sch.Med.Univ.Yamanashi

Oral Sessions

Glia Cell (4)

3-O-C2-115:3015:42 Chemogenetic activation of astrocytes in the ventral hippocampus Eiji Shigetomi, Schuichi Koizumi Dept. Neuropharmacol. Interdiscipl. Grad. Sch. Med., Univ. Yamanashi

3-O-C2-215:4215:54 Neuronal excitation mechanism through activation of astrocytic P2Y1 receptor. Suzuki Hideaki¹, Eiji Shigetomi¹, Yukiho Hirayama¹, Fumikazu Sano¹, Kenji Tanaka², Haruhiko Bito³, Schuichi Koizumi¹ ¹Dept Neuropharmacol, Interdiscipl Grad Sch Med, Univ Yamanashi, ²Dept Neuropsych, Keio Univ Sch Med, ³Dept Neurochem, Grad Sch Med, Univ Tokyo

3-O-C2-315:5416:06 Astrocytic density tunes presynaptically silent synapses Shutaro Katsurabayashi, Kohei Oyabu, Kotomi Takeda, Kaori Kubota, Takuya Watanabe, Katsunori Iwasaki Dept. of Neuropharmacol., Fac of Pharmaceut. Sci., Fukuoka Univ.

3-O-C2-416:0616:18 Differential adrenergic regulation of process formation in cortical and spinal cord astrocytes Taisuke Kitano, Ryota Eguchi, Ken-ichi Otsuguro Lab. Pharmacol. Fac. Vet. Med. Hokkaido Univ.

3-O-C2-516:1816:30 Hydrogen sulfide increases intracellular Ca²⁺ concentration by inhibition of mitochondrial respiration in cultured rat spinal cord astrocytes. Nii Takeshi, Ryota Eguchi, Ken-ichi Otsuguro Lab. Pharmacol. Fac. Vet. Med. Hokkaido Univ.